DE69738353D1 - Radiometall-bindende peptide analoge - Google Patents

Radiometall-bindende peptide analoge

Info

Publication number
DE69738353D1
DE69738353D1 DE69738353T DE69738353T DE69738353D1 DE 69738353 D1 DE69738353 D1 DE 69738353D1 DE 69738353 T DE69738353 T DE 69738353T DE 69738353 T DE69738353 T DE 69738353T DE 69738353 D1 DE69738353 D1 DE 69738353D1
Authority
DE
Germany
Prior art keywords
radiometall
binding peptide
peptide analog
peptide
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738353T
Other languages
English (en)
Other versions
DE69738353T2 (de
Inventor
William J Mcbride
Gary L Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Application granted granted Critical
Publication of DE69738353D1 publication Critical patent/DE69738353D1/de
Publication of DE69738353T2 publication Critical patent/DE69738353T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69738353T 1996-07-12 1997-07-11 Radiometall-bindende peptide analoge Expired - Lifetime DE69738353T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2166296P 1996-07-12 1996-07-12
US21662P 1996-07-12
PCT/US1997/012084 WO1998002192A1 (en) 1996-07-12 1997-07-11 Radiometal-binding peptide analogues

Publications (2)

Publication Number Publication Date
DE69738353D1 true DE69738353D1 (de) 2008-01-17
DE69738353T2 DE69738353T2 (de) 2009-09-24

Family

ID=21805465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738353T Expired - Lifetime DE69738353T2 (de) 1996-07-12 1997-07-11 Radiometall-bindende peptide analoge

Country Status (8)

Country Link
US (2) US6126916A (de)
EP (1) EP0975374B1 (de)
JP (1) JP3647881B2 (de)
AT (1) ATE380038T1 (de)
AU (1) AU725827B2 (de)
DE (1) DE69738353T2 (de)
ES (1) ES2297862T3 (de)
WO (1) WO1998002192A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6027711A (en) * 1995-06-07 2000-02-22 Rhomed Incorporated Structurally determined metallo-constructs and applications
US6395255B1 (en) * 1998-06-15 2002-05-28 Thomas Jefferson University Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7387772B1 (en) * 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
US7138103B2 (en) 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
AU760257B2 (en) * 1998-12-14 2003-05-08 Palatin Technologies, Inc. Metallopeptide combinatorial libraries and applications
AU1623801A (en) * 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US6693165B2 (en) 2000-01-18 2004-02-17 Merck & Co., Inc. Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
AU2002238106A1 (en) * 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
US7893223B2 (en) 2001-07-17 2011-02-22 Bracco Imaging S.P.A. Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
WO2003101495A1 (en) * 2002-05-29 2003-12-11 Immunomedics, Inc. Methods and compositions for radioimmunotherapy of brain and cns tumors
US20040022726A1 (en) * 2002-06-03 2004-02-05 Goldenberg David M. Methods and compositions for intravesical therapy of bladder cancer
US20060167229A1 (en) * 2002-12-18 2006-07-27 Wai Ming Wong Biologically active peptide conjugates
AU2003303714B2 (en) * 2003-01-13 2009-02-19 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds
CA2529027C (en) 2003-06-13 2013-09-10 Immunomedics, Inc. D-amino acid peptides
JP2007524649A (ja) * 2003-07-29 2007-08-30 イミューノメディクス、インコーポレイテッド フッ素化炭水化物複合体
EP1749026B1 (de) 2004-05-24 2011-11-23 Institut de Cardiologie de Montréal Markierte adrenomedullinderivate und deren verwendung zur bilddarstellung und therapie
WO2005123761A1 (en) * 2004-06-21 2005-12-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem GnRH ANALOGS BACKBONE CYCLIZED THROUGH METAL COMPLEXATION
BRPI0607486B8 (pt) 2005-03-03 2021-05-25 Immunomedics Inc anticorpo humanizado l243 contra hla-dr presente nas células hladr+,composição farmacêutica, kit e uso dos referidos anticorpos.
EP1700608A1 (de) 2005-03-10 2006-09-13 Schering AG Chelate für radioaktiv markierte Konjugate mit einer stabilisierenden Seitenkette
EP2674440B1 (de) 2005-12-16 2019-07-03 IBC Pharmaceuticals, Inc. Polyvalente bioaktive anordnungen auf immunglobulinbasis
JP5312328B2 (ja) 2006-09-07 2013-10-09 シーメンス アクチエンゲゼルシヤフト 減衰調節装置および減衰調節方法
CN102143970B (zh) * 2008-05-27 2017-02-08 健赞股份有限公司 α‑促黑素细胞激素的肽类似物
TWI394585B (zh) * 2008-07-25 2013-05-01 Iner Aec Executive Yuan The magnetic fluid used for the development or treatment of peptides
US9441013B2 (en) 2011-05-17 2016-09-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanocortin 1 receptor ligands and methods of use
US9290539B2 (en) 2011-05-17 2016-03-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Melanotropin ligands for skin care
US9821023B2 (en) 2014-06-10 2017-11-21 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for the treatment of central nervous system (CNS) disorders and mood disorders
US20170022252A1 (en) 2014-06-10 2017-01-26 The Arizona Board Of Regents On Behalf Of The University Of Arizona Novel modulators of melanocortin receptors
US9814755B2 (en) 2014-06-10 2017-11-14 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for the treatment of depression and anxiety
BR112017010414A2 (pt) 2014-11-25 2018-05-15 Bristol-Myers Squibb Company métodos e composições para radiomarcação com 18f de substâncias biológicas
US10550157B2 (en) 2015-10-16 2020-02-04 Arizona Board Of Regent On Behalf Of The University Of Arizona Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
LT3458111T (lt) 2016-05-19 2021-05-25 Bristol-Myers Squibb Company Pet vizualizacijos imunomoduliatoriai
WO2017210335A1 (en) 2016-06-01 2017-12-07 Bristol-Myers Squibb Company Imaging methods using 18f-radiolabeled biologics

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3162537D1 (en) * 1980-12-19 1984-04-12 Nihon Mediphysics Co Ltd 3-aminomethylene-2,4-pentanedione bis(thiosemicarbazone) derivatives, and their production and use
US4822890A (en) * 1983-05-20 1989-04-18 Hoffmann-La Roche Inc. Method for the production of amino terminus protected naturally occurring amino acids
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
DE69018226T2 (de) * 1989-07-20 1995-09-21 Sandoz-Patent-Gmbh, 79539 Loerrach Markierte polypeptidderivate.
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
CA2363780C (en) * 1993-04-08 2003-01-07 Diatide, Inc. Radiolabeled compounds for thrombus imaging
EP0697884B1 (de) * 1993-05-14 1999-11-17 Mallinckrodt Inc. Die vorstufe eines liganden zum einbau in peptide
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US5746996A (en) * 1994-06-03 1998-05-05 Immunomedics, Inc. Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
IL113610A0 (en) * 1994-06-03 1995-08-31 Immunomedics Inc A method of radiolabeling a protein, radiolabeled proteins prepared thereby and diagnostic kits containing the same
US5539138A (en) * 1994-07-28 1996-07-23 Merck Frosst Canada, Inc. High affinity chelates containing isothiocyanate groups, useful for coupling with peptides and proteins
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5753206A (en) * 1995-06-07 1998-05-19 Immunomedics, Inc. Radiometal-binding analogues of luteinizing hormone releasing hormone

Also Published As

Publication number Publication date
WO1998002192A1 (en) 1998-01-22
US6126916A (en) 2000-10-03
US7045503B1 (en) 2006-05-16
DE69738353T2 (de) 2009-09-24
ES2297862T3 (es) 2008-05-01
JP3647881B2 (ja) 2005-05-18
AU3724997A (en) 1998-02-09
EP0975374A1 (de) 2000-02-02
ATE380038T1 (de) 2007-12-15
AU725827B2 (en) 2000-10-19
JP2000515514A (ja) 2000-11-21
EP0975374B1 (de) 2007-12-05
EP0975374A4 (de) 2004-05-26

Similar Documents

Publication Publication Date Title
DE69738353D1 (de) Radiometall-bindende peptide analoge
DE69635080D1 (de) Radiometall-bindende analoge von lhrh
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
EP0679093A1 (de) Methode zum überbringen von agenzien an zielzellen.
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
GR3024489T3 (de)
CA2149333A1 (en) Eck receptor ligands
HK1016018A1 (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
ID18205A (id) Komposisi poliester mengandung bahan penyerap infra merah untuk memperbaiki pemanasan kembali
HUP0100426A3 (en) Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors, medicament containing them and their use
EP0724456A4 (de) Antikörper gegen cd40
DE69836217D1 (de) Chimäres lösliches interleukin-6 rezeptor/ligand protein, analoge und verwendungen
DE58902029D1 (de) Ladeluftkuehler, dichtung und verfahren zum zusammenbau des ladeluftkuehlers.
ATE296312T1 (de) Metalkomplexbildner
EP0739350A4 (de) Fas-antigenbindender ligand
DE69112015D1 (de) Schutzgasgemisch zum Schweissen von Superlegierungen.
DE69712124D1 (de) Hormones de croissance humaines mutantes et leur utilisation
HUP9901375A3 (en) Novel peptides suitable for use in antigen specific immunosuppressive therapy
AU3602695A (en) Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
IL129359A0 (en) Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
CA2259950A1 (en) Radiometal-binding peptide analogues
MY102593A (en) Antigents of plasmodium falciparum
CA2168775A1 (en) Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
GB2241702B (en) Antibodies which bind to the stratum corneun and their use as drug vectors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition